Industrial biotechnology, biochemistry and risk analysis
As so often, last week’s activities seemed to cluster on a subset of activities. We had a very useful third meeting of the Industrial Biotechnology (IB) Leadership Forum (and see its latest Newsletter), with updates on a wide range of topics. These included the Centre for Process Innovation at Wilton, home of the National Industrial Biotechnology Facility (see also the BIS Manufacturing and Materials Newsletter), activities at the European Forum for Industrial Biotechnology meeting in Edinburgh (and see video) and others that week, Industrial Biotechnology as a core part of the Knowledge-Based BioEconomy (a term that had actually originated under the UK and German EU Presidencies around 2005/6), the development of necessary skills (led by David Brown of the IChemE), and a presentation by Iain Wilcock of Seventure on the (venture capital) funding of Industrial Biotechnology. I outlined where we were with our own developments, while Jonathon Porritt, representing Forum for the Future, led a discussion of the possible (perceived and real) risks of introducing new technologies such as IB, and how we should develop relevant public engagement activities. [...]